Skip to content

Ceftobiprole

DRUG8 trials

Sponsors

Basilea Pharmaceutica, Azienda Sanitaria-Universitaria Integrata di Udine

Conditions

Antimicrobial AgentCephalosporinsDrug ResistanceIntracerebral HemorrhageObesityStaphylococcal Skin InfectionsStreptococcal InfectionsSubarachnoid Hemorrhage

Phase 1

Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone
CompletedNCT00771524
Basilea PharmaceuticaTotal Hip Replacement Surgery
Start: 2009-04-30End: 2010-02-28Updated: 2012-07-30
Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
TerminatedNCT00771719
Basilea PharmaceuticaVentilator Associated Pneumonia
Start: 2008-10-31End: 2009-11-30Updated: 2012-07-30
Effect of Ceftobiprole on Human Intestinal Microflora
CompletedNCT00965042
Basilea PharmaceuticaAntimicrobial Agent, Cephalosporins, Drug Resistance
Start: 2009-04-30End: 2009-06-30Updated: 2012-07-30
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
CompletedNCT01026636
Basilea PharmaceuticaStaphylococcal Skin Infections, Streptococcal Infections
Start: 2007-08-31End: 2010-04-30Updated: 2012-07-27
A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
CompletedNCT01026558
Basilea PharmaceuticaObesity, Staphylococcal Skin Infections, Streptococcal Infections
Start: 2007-08-31End: 2007-11-30Updated: 2012-08-28
Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
CompletedNCT01026740
Basilea PharmaceuticaStaphylococcal Skin Infections, Streptococcal Infections
Start: 2007-06-30End: 2007-09-30Updated: 2012-07-30
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
CompletedNCT01030731
Basilea PharmaceuticaStaphylococcal Skin Infections, Streptococcal Infections
Start: 2007-05-31End: 2007-08-31Updated: 2012-08-28

Unknown Phase